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Summary
In response to nutrients, energy sufficiency, hor-
mones, and mitogenic agents, S6K1 phosphorylates
several targets linked to translation. However, the mo-
lecular mechanisms whereby S6K1 is activated, en-
counters substrate, and contributes to translation ini-
tiation are poorly understood. We show that mTOR
and S6K1 maneuver on and off the eukaryotic initia-
tion factor 3 (eIF3) translation initiation complex in a
signal-dependent, choreographed fashion. When in-
active, S6K1 associates with the eIF3 complex, while
the S6K1 activator mTOR/raptor does not. Cell stimu-
lation promotes mTOR/raptor binding to the eIF3 com-
plex and phosphorylation of S6K1 at its hydrophobic
motif. Phosphorylation results in S6K1 dissociation,
activation, and subsequent phosphorylation of its
translational targets, including eIF4B, which is then
recruited into the complex in a phosphorylation-
dependent manner. Thus, the eIF3 preinitiation com-
plex acts as a scaffold to coordinate a dynamic se-
quence of events in response to stimuli that promote
efficient protein synthesis.
Introduction
Signal transduction pathways modulate cellular pro-
cesses in eukaryotic cells in response to a variety of
stimuli. The ability of a cell to respond to these stimuli
depends in part on production of specific effector pro-
teins. Traditionally, it was thought that the change in the
proteome occurred as a result of transcriptional activ-
ity. However, we now know that regulating translation
of specific messages is another way of altering protein
production (Nilsson et al., 2004). The limiting step in
the process of protein synthesis is translation initiation.
Thus, it is important to understand how signal trans-
duction pathways target and activate protein synthe-
sis initiation.
The mammalian target of rapamycin, mTOR, has
emerged as a critical nutritional and cellular energy
checkpoint sensor and regulator of cell growth in mam-
malian cells (Gingras et al., 2001; Richardson et al.,
2004; Schmelzle and Hall, 2000). This large protein ser-
ine/threonine kinase is a member of the PIKK family
of protein kinases (Richardson et al., 2004) and, when
complexed with the protein raptor, is very potently in-
hibited by the naturally occurring antifungal macrolide
rapamycin (Kim et al., 2002). mTOR modulates the ac-*Correspondence: jblenis@hms.harvard.edutivity of two important translational regulators, the ribo-
somal S6 kinases (S6K1 and S6K2) and the eukaryotic
initiation factor 4E (eIF4E), following changes in amino
acid levels and energy sufficiency as well as stimulation
by hormones and mitogens. These mTOR-regulated ef-
fectors control cell size and contribute to efficient G1
cell-cycle progression (Fingar and Blenis, 2004). Im-
proper regulation of eIF4E and S6Ks contributes to car-
cinogenesis in cells with loss-of-function mutations in
the tumor suppressors PTEN, TSC1/2, or LKB or upon
gain-of-function mutations in many growth-factor re-
ceptors, phosphatidylinositol 3-kinase (PI3K), or Akt
(protein kinase B) (Bjornsti and Houghton, 2004; Inoki
et al., 2005; Tee and Blenis, 2005). In addition, inappro-
priate mTOR signaling can contribute to metabolic dis-
eases such as diabetes and obesity (Hay and Sonen-
berg, 2004). Finally, more recent evidence has linked
mTOR signaling to synaptic plasticity, memory, and
general neuronal physiology (Kelleher et al., 2004).
mTOR regulates the function of eIF4E by regulating
the phosphorylation of the eIF4E inhibitory proteins, 4E
binding proteins (4E-BPs). Phosphorylation of 4E-BP1
promotes its dissociation from eIF4E bound to the
mRNA 7-methylguanosine cap structure, allowing for
recruitment of eIF4G and eIF4A. eIF3, 40S ribosomal
subunits, and the ternary complex (eIF2/Met-tRNA/
GTP) are also recruited to the cap, resulting in the as-
sembly of the translation preinitiation complex (PIC) (for
review, see Hay and Sonenberg, 2004). It is unclear how
eIF4B, an essential regulatory subunit of the helicase
eIF4A, is recruited to the PIC.
mTOR initiates S6K activation in response to cellular
energy status, nutrient levels, and mitogens. Full and
sustained S6K activation requires additional inputs by
PI3K-dependent and -independent mechanisms and
requires multiple growth-factor-induced phosphoryla-
tion events (Fingar and Blenis, 2004; Inoki et al., 2005;
Martin and Blenis, 2002). Two essential phosphoryla-
tion sites include T229, located within the catalytic acti-
vation loop, and T389, located at the hydrophobic motif
(reviewed in Martin and Blenis, 2002). S6K1 activation
is initiated by mTOR/raptor-mediated phosphorylation
of T389 (Kim et al., 2002), which requires the TOS motif
located at the N terminus of S6K1 (Nojima et al., 2003;
Schalm and Blenis, 2002). T389 phosphorylation cre-
ates a docking site for the phosphoinositide-dependent
kinase 1 (PDK1), which then phosphorylates T229
(Alessi et al., 1998; Frodin et al., 2002). Following the
initiating phosphorylation at T389 by mTOR, phosphor-
ylation at this site is maintained by an agonist-regulated
autophosphorylation mechanism (Romanelli et al., 2002).
It is unclear how regulation of S6K1 by these multiple
kinases is coordinated. We show that the eIF3 transla-
tion preinitiation complex serves an important function
in organizing and coordinating this complex series of
events.
An important question regarding S6K1 signaling is
the molecular mechanics of how S6K1 coordinates the
phosphorylation and function of proteins involved in
regulating protein synthesis. S6K-mediated control of
Cell
570translation was thought to occur through phosphoryla-
tion of the 40S ribosomal protein S6. The increase in
S6 phosphorylation was proposed to govern the trans-
lation of a specific subset of mRNAs containing 5#-ter-
minal oligopyrimidine (5#-TOP) tracts encoding ribo-
somal components and translation elongation factors
(Jefferies et al., 1997); however, this model has been
recently challenged (Pende et al., 2004; Tang et al.,
2001). It now appears that S6K1, but not S6K2 and S6
phosphorylation, is linked to cellular growth control
(Pende et al., 2004). Thus, the mechanism by which
mTOR-regulated S6K1 mediates its effects on transla-
tion and cell growth remains a mystery.
One potentially important target of the S6 kinases in
modulating protein synthesis is eIF4B, which is phos-
phorylated by S6Ks in vitro and in vivo (Gingras et al.,
2001). The consequence of eIF4B phosphorylation on
the process of translation initiation, however, remains
unclear (Gingras et al., 2001). The S6Ks may also con-
tribute to translation elongation, as they have been
shown to phosphorylate eukaryotic elongation factor 2
(eEF2) kinase (Wang et al., 2001). Again, it is not clear
how this contributes to translational regulation.
The eukaryotic translation initiation factor 3 (eIF3) is
a complex consisting of at least 12 subunits (Mayeur et
al., 2003). eIF3 interacts with the 40S ribosomal subunit
as part of the 43S translation preinitiation complex and
plays a role in eIF2/Met-tRNA/GTP ternary-complex as-
sociation and mRNA binding (Gingras et al., 2001). The
mRNA helicase complex, eIF4A/4B, also associates
with the preinitiation complex and is important in un-
winding complex 5#UTRs for efficient translation
(Methot et al., 1996). Significantly, eIF3 subunits are fre-
quently overexpressed in a variety of human cancers
(Rajasekhar and Holland, 2004), which suggests a link
between the aberrant regulation of translation initiation
and neoplastic transformation.
Here, we present a connection between the mTOR/
S6K1 pathway and translation initiation. We show that
the eIF3 complex acts as a scaffolding platform that
associates with mTOR and S6K1 in a growth-factor-
and rapamycin-sensitive manner, with mTOR associat-
ing with the eIF3 translation preinitiation complex and
S6K1 dissociating from the eIF3 complex upon hor-
mone or mitogenic stimulation. This sequence of events
promotes the coordinated phosphorylation and activa-
tion of S6K1 and the phosphorylation of the 40S ri-
bosomal protein S6 and eIF4B, a process that was
previously unclear. Phosphorylation of eIF4B then con-
tributes to its association with the translation preinitia-
tion complex, where it is predicted to partner with
eIF4A to form a fully functional mRNA helicase (Rogers
et al., 1999, 2001). The results presented here demon-
strate a role for eIF4B phosphorylation in stimulating its
recruitment to the translation preinitiation complex and
uncover a regulated mechanism by which mTOR and
S6K1 signaling is integrated into the process of transla-
tion initiation.
Results
Purification of eIF3-Complex Subunits as S6K1
Binding Proteins
In order to identify novel ways by which S6Ks might
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Tregulate protein translation, we sought to purify S6K1-ssociated proteins by employing the tandem-affinity
urification (TAP) approach. We stably introduced
BABE vector expressing S6K1 with a dual HA and Pro-
ein A epitope tag into HEK293E cells and purified the
ssociated proteins by a two-step procedure. S6K1-
nteracting proteins were eluted with MgCl2 from the
A column in the second step of the purification as
reviously described (Ballif et al., 2004) and separated
y SDS-polyacrylamide gel electrophoresis. The gel
as stained with Coomassie brilliant blue, revealing a
umber of proteins that interacted with S6K1 but not
ith Protein A alone (Figure 1A). Protein bands were
xcised and analyzed by mass spectrometry. Two of
hese proteins were identified as subunits p40 and p47
f the translation initiation factor eIF3 complex (eIF3h
nd eIF3f). The copurification of the eIF3-complex sub-
nits was also confirmed by other immunoprecipi-
ations in which we identified core subunits eIF3c and
IF3b, as well as eIF3e complexed with S6K1 in growing
EK293E cells (data not shown).
he Interaction of the eIF3 Complex and S6K1 Is
egulated by Hormones, Mitogens, Phorbol Esters,
mino Acids, and Rapamycin
fter identifying members of the eIF3 complex in the
6K1 bound fraction by TAP, we set out to confirm this
nteraction and investigate its regulation. As shown in
igure 1B, HA-S6K1 coimmunoprecipitated with the
ore subunits b and c of the eIF3 complex under se-
um-starved conditions in HEK293E cells. Strikingly,
his interaction was potently disrupted by insulin stimu-
ation. Moreover, pretreatment with rapamycin restored
he binding of eIF3 to S6K1.
We next verified that endogenous S6K1 exhibited the
ame regulated interaction with the eIF3 complex. Fig-
re 1C shows that endogenous S6K1 coimmunopreci-
itated with endogenous eIF3b under serum-starved
nd rapamycin-treated conditions but not after stimula-
ion with insulin. The same pattern was observed when
ells were stimulated with phorbol 12-myristate 13-ace-
ate (PMA) or epidermal growth factor (EGF) and ana-
yzed for the presence of S6K1 in eIF3b immunoprecipi-
ates (Figure 1D). Again, the interaction observed under
onstimulated conditions was strongly disrupted by mi-
ogen stimulation and restored by pretreatment with ra-
amycin. We also examined whether the S6K1/eIF3-
omplex interaction was observed in another cell type.
s shown in Figure S1A in the Supplemental Data avail-
ble with this article online, in serum-starved HeLa
ells, S6K1 was associated with the eIF3 complex, and
his interaction was disrupted by insulin addition and
estored by rapamycin pretreatment. Thus, both endog-
nous and overexpressed S6K1 form a complex with
IF3 under conditions where S6K1 was not activated,
nd dissociation of S6K1 from the eIF3 complex by in-
ulin, growth factors, or tumor-promoting phorbol es-
ers was blocked by rapamycin. Finally, we determined
hether amino acid availability, which also regulates
TOR signaling, modulated the S6K1/eIF3 interaction.
s shown in Figure 1E, in nutrient-starved U2OS and
eLa cells, S6K1 was associated with the eIF3 com-
lex, and this interaction was disrupted by amino acid
ddition and was restored by rapamycin pretreatment.
hus, nutrient availability also regulates the S6K1 andeIF3 interaction.
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571Figure 1. Purification of eIF3-Complex Subunits as S6K1 Binding Proteins and Identification of the eIF3 Preinitiation Complex as a Regulated
Binding Partner of S6K1
(A) HA-tagged S6K1 was cloned in frame with the IgG binding domain of Protein A separated by a TEV cleavage site (TAP-S6K1). TAP elution
was performed as described in Experimental Procedures, and eluants from control (Protein A alone) or S6K1 columns were resolved by SDS-
PAGE. Arrows indicate the positions of S6K1-associated proteins eIF3f and eIF3h.
(B) Endogenous eIF3 core subunits interact with HA-S6K1. HEK293E cells were transfected with HA-S6K1, deprived of serum, stimulated,
and lysed as described in Experimental Procedures. Endogenous eIF3c and eIF3b were immunoprecipitated, and their interaction with HA-
S6K1 was determined by immunoblotting. Protein levels of eIF3b and eIF3c in immunoprecipitates and HA-S6K1 in the lysates are shown by
immunoblotting with the respective antibodies.
(C) Endogenous S6K1 interacts with endogenous eIF3b. Endogenous S6K1 was immunoprecipitated and assayed for interaction with endoge-
nous eIF3b. Protein levels of eIF3b in immunoprecipitates and S6K1 and eIF3b in the lysates are shown.
(D) Endogenous eIF3 and S6K1 interaction is regulated by various stimuli. Endogenous eIF3b was immunoprecipitated and assayed for
interaction with endogenous S6K1 after stimulation with insulin, PMA, or EGF or pretreatment with rapamycin. Protein levels of S6K1 and
eIF3b in immunoprecipitates and S6K1 and phospho-S6 (P-S6) in the lysates are shown.
(E) eIF3 interaction with S6K1 is regulated in U2OS and HeLa cells by addition of amino acids. Cells were starved of amino acids, stimulated,
and lysed as described in the Experimental Procedures. eIF3b was immunoprecipitated, and the interaction with S6K1 is shown by immu-
noblot analysis. Levels of S6K1 and phospho-S6 (P-S6) in the lysates are shown. These data are representative of greater than three indepen-
dent experiments.Since our results suggested that the inactive, hypo-
phosphorylated form of S6K1 associates with eIF3 and
that activation correlates with its dissociation, we ex-
amined whether kinases that are involved in activation
of S6K1 interact with the eIF3 complex. Specifically, we
immunoprecipitated eIF3b from HEK293E cells and as-
sayed for binding of endogenous Akt and PDK1. As de-
picted in Figure S1B, we found that Akt was not de-
tected in eIF3b immunoprecipitates. Importantly, we
also found that PDK1, which associates with the hy-
drophobic motif of S6K1 when it is phosphorylated
(Figure S1C and Frodin et al., 2002), did not interact
with eIF3 (Figure S1B). Therefore, the association be-
tween S6K1 and the eIF3 complex appears to be spe-
cific and does not extend to other closely related AGC
kinases. Additionally, we were able to detect some HA-
S6K2 binding to eIF3; however, under the conditions of
our experiments, its association was not regulated by
insulin or rapamycin (data not shown). Thus, only S6K1
demonstrates a regulated interaction with the eIF3complex. To further characterize the association of S6K1
with eIF3, the eIF3:40S preinitiation complex, and poly-
somes, we separated these complexes by sucrose-gra-
dient fractionation of cell extracts. Fractionation of ex-
tracts from cells incubated with insulin (Figure S2A) or
insulin plus rapamycin (Figure S2B) revealed fractions
in the low-density portion of the gradient that contained
eIF3 but no 40S subunits, as determined by the ab-
sence of the 40S ribosomal protein S6; medium-density
fractions containing eIF3 plus 40S subunits, represent-
ing preinitiation complexes; and high-density fractions
containing little eIF3 but with 40S subunits as expected
in polysomes. eIF3 and the 40S subunits failed to sedi-
ment to the high-density fractions if cells were treated
with rapamycin (Figure S2B), as previously described
(Miyamoto et al., 2005). We further analyzed fractions 4
and 5 (containing predominantly eIF3) and fractions 13
and 14 (containing preinitiation complexes) as depicted
in Figure S2C and could only detect significant amounts
of S6K1 to copurify with eIF3 in low-density fractions 4
Cell
572and 5 after pretreatment with rapamycin. The lack of
S6K1 in fractions 4 and 5 obtained from insulin-stim-
ulated cell extracts demonstrated that this protein of
approximately 70 kDa could not enter the gradient after
its insulin-mediated release from the eIF3 complex.
Therefore, S6K1 likely associates with eIF3-containing
complexes in the absence of the 40S ribosome. With-
out a clearer understanding of the molecular basis for
the interaction of S6K1 with eIF3 complexes in unstim-
ulated or rapamycin-treated cells, however, we propose
to define the eIF3 complex in our coimmunoprecipita-
tion experiments as part of the eIF3 translation preiniti-
ation complex, or eIF3-PIC.
The Phosphorylation of the Hydrophobic Motif
at T389 Regulates the Interaction between
S6K1 and the eIF3-PIC
The data presented above provide evidence that the
activation state of S6K1 governs its binding to the eIF3-
PIC. Thus, we tested an array of mutants of S6K1 for
their ability to coimmunoprecipitate with the eIF3 com-
plex. The positions of these mutations in S6K1 are dia-
grammed in Figure 2A. First, we examined the kinase-
inactive (KD) mutant of S6K1 (containing a K100R
mutation in the ATP binding site), the kinase-inactive
TOS-motif mutant (F5A), and the kinase-inactive T229A
mutant (containing a mutation at the phosphorylation
site within the activation loop). As shown in Figure 2B,
we found that, unlike the regulated interaction between
wild-type S6K1 and eIF3, the kinase-inactive mutants
of S6K1 bound constitutively to the eIF3 complex. The
results with the F5A-S6K1 mutant also demonstrate
that the binding of S6K1 to the eIF3 complex is not
mediated by the TOS motif. These data are consistent
with the observation that S6K1 phosphorylation, which
correlates with its activation, promotes its dissociation
from the eIF3-PIC.
Mutation of the TOS motif or the activation loop of
S6K1 prevents phosphorylation of T389 (the hydropho-
bic motif), an important mTOR-regulated phosphoryla-
tion site necessary for its activation. We therefore hy-
pothesized that the interaction between eIF3-PIC and
S6K1 might be sensitive to mTOR-modulated S6K1
T389 phosphorylation. Thus, we investigated whether
mutations at this site would affect the S6K1:eIF3-PIC
interaction. The T389E mutation mimics phosphoryla-
tion of the hydrophobic motif and renders the kinase
more active under basal conditions, still partially re-
sponsive to growth factors, and partially rapamycin re-
sistant (see lower panel of Figure 2C and Schalm et al.,
2005). As shown in Figure 2C, the T389E mutation
greatly reduced eIF3 association with S6K1 under all
conditions, similar to the behavior of activated S6K1.
Importantly, the T389A mutation had the opposite effect
compared to the T389E mutation: the T389A mutant
constitutively bound to eIF3-PIC in a manner similar to
the kinase-dead and F5A mutants. Therefore, the in-
teraction between S6K1 and eIF3-PIC appears to be
regulated by mTOR-dependent phosphorylation of S6K1
at T389.
We confirmed the contribution of S6K1 T389 phos-
phorylation to binding eIF3-PIC in the context of other
mutations. We previously identified a stretch of three
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srginine residues in the C terminus of S6K1 that medi-
tes an inhibitory effect on T389 phosphorylation, as
utation of these arginine residues to alanines (R3A)
escued the inhibition brought about by the F5A muta-
ion and rendered the kinase rapamycin resistant
Schalm et al., 2005). As shown in Figure 2D, a combi-
ation of the F5A and R3A mutations allowed S6K1 to
ind to eIF3b under basal conditions and dissociate
rom eIF3 after insulin stimulation. However, because
he F5A-R3A mutant is rapamycin resistant, pretreat-
ent with rapamycin did not restore the association
etween S6K1 and eIF3. Significantly, the combination
f F5A-R3A and the hydrophobic-motif mutation T389E
F5A-389E-R3A) dramatically reduced S6K1 binding to
IF3, similar to T389E mutation alone. Finally, the
100R-T389E mutant, which is catalytically inactive but
arries a phosphomimetic mutation at the hydrophobic
otif, does not interact with the eIF3 complex (Figure
E). Therefore, the activation of S6K1 is not required
er se for dissociation of S6K1 from the eIF3-PIC scaf-
old. This interaction appears to be regulated by phos-
horylation of T389.
he eIF3-PIC Interacts with mTOR/Raptor
ecause our data pointed to the involvement of mTOR-
ediated T389 phosphorylation in the ability of S6K1
o dissociate from eIF3-PIC, we tested the possibility
hat mTOR, in association with its binding partner rap-
or, would also be part of the eIF3-PIC. To test this hy-
othesis, HEK293E cells were transfected with AU-
agged mTOR and myc-raptor. Cells were lysed, and
he complexes were immunoprecipitated using anti-
odies against the endogenous eIF3b and eIF3c. To our
urprise, not only did mTOR and raptor coimmunopre-
ipitate with the eIF3 complex, but the interaction be-
ween mTOR/raptor and eIF3-PIC followed the pattern
pposite of that of S6K1. Raptor and mTOR, which
ere weakly associated with eIF3 under serum-starved
nd rapamycin-treated conditions, bound strongly to
IF3c immunocomplexes following insulin stimulation
Figure 3A). Pretreatment with rapamycin reduced the
nsulin-mediated binding of mTOR/raptor to the eIF3
omplex to basal levels. Similar results were obtained
hen immunoprecipitating endogenous raptor and mTOR
Figure 3B), although when monitoring endogenous
roteins we noted lower levels of raptor binding in un-
timulated or rapamycin-treated conditions. Therefore,
pon insulin treatment, mTOR/raptor associates with
IF3-PIC, whereas S6K1 dissociates from the complex.
o further characterize the interaction of mTOR with
IF3, eIF3:40S preinitiation complex, and polysomes,
e separated these complexes by sucrose-gradient
ractionation as shown and discussed for S6K1 (Figure
2). Importantly, unlike S6K1, we detected increased
evels of mTOR copurifying with both low- and high-
olecular-weight eIF3-containing complexes from cells
ncubated with insulin but not insulin plus rapamycin
Figure S2C; compare low-density fractions 4 and 5 to
edium-density fractions 13 and 14). Taken together,
hese data suggest that the eIF3-PIC acts as a dynamic
caffold for mTOR and S6K1.
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573Figure 2. The Phosphorylation of the Hydrophobic Motif at T389 Regulates the Interaction between S6K1 and eIF3-PIC
(A) Schematic representation of the mutations in S6K1.
(B) Interaction of S6K1 mutants with eIF3b. HEK293E cells were transfected with wild-type (WT), F5A, K100R, and T229A alleles of HA-S6K1;
deprived of serum; stimulated; and lysed as described in Experimental Procedures. eIF3b was immunoprecipitated and assayed for interaction
with HA-S6K1 mutants by immunoblot analysis. Protein levels of eIF3b in the immunoprecipitates and HA-S6K1 and phospho-T389 in the
lysates are shown by immunoblot analysis. The kinase activity of the S6K1 alleles toward GST-S6 was measured and quantified in the his-
togram.
(C) Same as in (B), with T389E and T389A alleles of S6K1.
(D) Same as in (B), with F5A-R3A and F5A-T389E-R3A.
(E) Same as in (B), with K100R-T389E. These data are representative of greater than three independent experiments.The eIF3-PIC Interacts with S6K1 Targets
Since inactive S6K1 is docked at the eIF3 complex prior
to agonist-induced translation initiation, we hypothe-
sized that nutrients and mitogens serve to bring S6K1
near its translational targets. Hence, when activated,
the tightly associated S6K1 is released from the eIF3
complex and is then able to phosphorylate these proxi-
mally associated proteins that regulate protein synthe-
sis. To examine this possibility, we investigated whether
the eIF3 complex associates with the 40S ribosome
and eIF4B, which are targets of S6K1. As shown in Fig-
ure 4A, in addition to free eIF3, a portion of eIF3 was
always associated with the 40S ribosome under our ex-
perimental conditions as monitored by immunoblotting
eIF3 immunoprecipitates with antibody recognizing 40Sribosomal protein S6 (also see Figure S2), but increased
S6 phosphorylation was only observed under condi-
tions where S6K1 was phosphorylated and released
from the eIF3-PIC. Interestingly, the association of
eIF4B with the eIF3-PIC, as monitored by immunoblot-
ting eIF3b immunoprecipitates with antibody recogniz-
ing eIF4B, was observed in insulin-stimulated but not
serum-starved cells. Regulated association of eIF4B
with the PIC had not been previously described. Fur-
thermore, the insulin-stimulated interaction was po-
tently disrupted by rapamycin treatment, suggesting
that this interaction may also be regulated by post-
translational events. Therefore, when S6K1 is activated,
its release from the eIF3 complex correlates with S6
phosphorylation and the association of eIF4B.
Cell
574Figure 3. eIF3-PIC Interaction with mTOR/Raptor Is Positively Regulated by Insulin
(A) Transfected mTOR/raptor interacts with the eIF3-PIC. HEK293E cells were transfected with AU-mTOR and myc-raptor, starved, stimulated,
and lysed as described in Experimental Procedures. eIF3c was immunoprecipitated and assayed for association with AU-mTOR/myc-raptor
by immunoblotting. Protein levels in lysates and immunoprecipitates are shown by immunoblot analysis. Control is untransfected cells.
(B) Endogenous mTOR/raptor interacts with the eIF3-PIC. eIF3b was immunoprecipitated and assayed for association with mTOR/raptor by
immunoblot. These data are representative of greater than three independent experiments.Previous studies have been unable to determine a
role for eIF4B phosphorylation. To test the hypothesis
that phosphorylation of eIF4B by S6K1 leads to its re-
cruitment to the eIF3-PIC, we used eIF4B phosphoryla-
tion mutants, nonphosphorylatable S422A, and phos-
phomimetic S422D. As depicted in Figure 4B, the
S422A mutant was unable to associate with the eIF3-
PIC under all conditions. Conversely, the S422D mutant
constitutively bound to eIF3-PIC. Therefore, phosphor-
ylation of eIF4B by activated S6K1 promotes its associ-
ation with the translation preinitiation complex.
The T389A Mutant of S6K1 Prevents eIF4B Binding
to the eIF3-PIC and the 7-Methylguanosine
Cap Complex
We wanted to support the hypothesis that S6K1 activa-
tion and release from the eIF3-PIC was needed for sub-
sequent phosphorylation of S6 and phosphorylation
and association of eIF4B with the eIF3 complex. To do
this, we overexpressed an inactive allele of S6K1 that
is constitutively bound to eIF3-PIC to determine
whether it would exhibit dominant-inhibitory activity
and thus prevent binding or phosphorylation of S6K1
targets. As shown in Figure 4C, overexpression of
T389A S6K1 inhibited the binding of eIF4B to eIF3-PIC
after insulin stimulation. Phosphorylation of the 40S ri-
bosomal S6 protein associated with eIF3 immunopreci-
pitates was also decreased when T389A S6K1 was ex-
pressed relative to phosphorylation of total cellular S6.
We also determined whether T389A S6K1 overexpres-
sion blocked the recruitment of S6K1 targets to the
7-methylguanosine cap complex. As shown in Figure
4D, upon insulin treatment, T389A S6K1 prevented
eIF4B binding to the 7-methylguanosine cap complex
and decreased S6 phosphorylation. However, the bind-
ing of eIF4G, 4E-BP1, and eIF4E, which are not S6K1
targets, was unaffected. Importantly, the binding of
eIF4G to the 7-methylguanosine cap complex corre-
lated with the recruitment of mTOR/raptor and phos-
phorylation and release of 4E-BP1.
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hemporal Association of Translational Components
ith eIF3-PIC and the 7-Methylguanosine
ap Complex
ur data suggested that, following growth-factor addi-
ion, mTOR/raptor associates with the eIF3 complex
nd phosphorylates and initiates activation of S6K1,
hich reduces its affinity for the complex and allows
t to phosphorylate downstream targets such as 40S
ibosomal protein S6 and the helicase subunit eIF4B.
hosphorylation of eIF4B then promotes its association
ith the translation preinitiation complex. To provide
dditional support for this model, we characterized the
emporal regulation of endogenous protein binding to
IF3-PIC. First, we found that mTOR/raptor rapidly as-
ociated with eIF3-PIC within minutes of insulin stimu-
ation. This correlated nicely with insulin-stimulated
hosphorylation of S6K1 and its dissociation from the
IF3 complex (Figure 5A).
As shown in Figure 5A, maximal S6 phosphorylation
agged behind the phosphorylation and dissociation of
6K1 from the eIF3 complex. Treatment with rapamycin
estored the binding of S6K1 to eIF3. Under these lysis
onditions, the 40S subunit protein S6 appeared to
oimmunoprecipitate with eIF3 throughout the time
ourse. However, our sucrose-gradient fractionation
nalysis suggests that this represents a pool of free
IF3 and eIF3:40S subunits (Figure S2) as previously
escribed (Miyamoto et al., 2005). Finally, we show that
he binding of eIF4B with the eIF3-PIC correlated with
ts maximal phosphorylation, and also the maximal
hosphorylation of S6—in other words, following phos-
horylation, release, and the subsequent activation of
6K1 (Figure 5A).
We next investigated whether the association of pro-
eins to eIF3-PIC occurred while it was docked at the
ap complex. As shown in Figure 5B, we found that
IF3 was associated with the 7-methylguanosine cap
omplex with or without insulin, and in the presence of
apamycin, under our purification conditions. Previous
tudies have suggested that eIF3 is recruited to the
-methylguanosine cap complex with eIF4G. We show,
owever, that overexpression of the TOS-motif mutant
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(A) Endogenous eIF4B and S6 interact with eIF3-PIC. Endogenous eIF3b was immunoprecipitated from HEK293E cells and tested for interac-
tion with S6 and eIF4B. The indicated protein and phosphoprotein levels were assayed by immunoblotting with their respective antibodies.
Control is beads alone.
(B) eIF4B binding to eIF3-PIC is regulated by serine 422 phosphorylation. The indicated alleles of FLAG-eIF4B were transfected into HEK293E
cells, and eIF3b was immunoprecipitated and blotted for interaction with eIF4B. Protein levels in lysates and immunoprecipitates are shown
by immunoblot analysis.
(C) T389A S6K1 prevents eIF4B binding to eIF3-PIC. eIF3b was immunoprecipitated from cells transfected with wild-type (WT) or T389A
mutant of S6K1 and assayed for interaction with eIF4B and S6. Protein and phosphoprotein levels in immunoprecipitates are shown by
immunoblot analysis.
(D) Binding of eIF4B to the 7-methylguanosine cap complex is inhibited by T389A S6K1. Cells were treated as indicated, precipitated from
cells transfected with wild-type (WT) or T389A mutant of S6K1, and assayed for interaction with the cap analog m7GTP coupled to beads.
Protein and phosphoprotein levels in precipitates and lysates are shown by immunoblot analysis. These data are representative of greater
than three independent experiments.of 4E-BP1 (F114A) (Schalm and Blenis, 2002; Schalm et
al., 2003), which prevents its dissociation from eIF4E
and therefore the association of eIF4G upon insulin
stimulation, does not prevent the copurification of eIF3
with the cap beads (Figure S3A). Furthermore, both
eIF4E and the eIF3 complex could be eluted from the
cap structure with free m7GTP (Figure S3C). We ob-
served that eIF4G binds to the cap complex in time-
dependent fashion upon insulin stimulation, whereas
4E-BP1 shows time-dependent dissociation from the
cap, both of which were rapamycin sensitive. eIF4E, on
the other hand, is constitutively present at the cap
complex. These data suggest that eIF3 may interact
with eIF4E. Given our data, we suggest a model where
the multiprotein eIF3 complex possesses binding sites
for eIF4E, eIF4G, mTOR/raptor, S6K1, and likely other
proteins that regulate translation initiation. Future work
will be needed to define the molecular basis for these
interactions. The association of eIF3 with the preinitia-
tion complex is likely stabilized following mTOR-depen-
dent phosphorylation and release of 4E-BP1 and thesubsequent recruitment of eIF4G. Importantly, in this
assay, mTOR and eIF4B demonstrated time-dependent
regulation of complex interaction upon insulin stimula-
tion. These results are consistent with the model where
recruitment of mTOR/raptor upon insulin stimulation
not only serves to initiate S6K1 T389 phosphorylation
and its dissociation, activation, and downstream sig-
naling from the eIF3 complex but also results in bring-
ing mTOR/raptor to the repressed eIF4E/4E-BP1 com-
plex, where it phosphorylates 4E-BP1, thus promoting
its dissociation. The scaffold protein eIF4G and associ-
ated proteins such as eIF4A then bind to the eIF4E/
cap complex to stabilize the eIF3-PIC, recruit additional
translation factors, and thus promote translation initi-
ation.
Insulin, Rapamycin, and Members of the mTOR
Signaling Pathway Regulate
Cap-Dependent Translation
Finally, we set out to determine whether the mTOR
pathway components contribute in vivo to cap-depen-
Cell
576Figure 5. Temporal Association of Translational Components with the eIF3-PIC and the 7-Methylguanosine Cap Complex
(A) Time course of binding of S6K1, mTOR/raptor, eIF4B, and eIF4G to eIF3. Cells were treated with insulin as indicated or pretreated with
rapamycin for 30 min (Rapa). Endogenous eIF3b was immunoprecipitated and assayed for interaction with the indicated endogenous proteins.
Levels of proteins and phosphoproteins in the immunoprecipitates and lysates are shown.
(B) Time course of protein association with the cap structure. Cells were treated as in (A), and the indicated proteins were assayed for
interaction with the cap analog m7GTP. These data are representative of greater than three independent experiments.dent translation. We used a dual-luciferase reporter
system, depicted in Figure 6A, to address this question
as described (Bordeleau et al., 2005; Kruger et al.,
2001). Using this assay, we first measured the effect of
insulin and rapamycin on cap-dependent translation.
As shown in Figure 6B, insulin led to a 2-fold increase
in cap-dependent over cap-independent translation
rates in serum-deprived cells, and this effect was com-
pletely rapamycin sensitive. This suggested that the in-
sulin-stimulated increase in cap-dependent translation
was modulated by signaling through the mTOR path-
way. To further define this observation, we measured
the effect of mTOR on cap-dependent translation. As
shown in Figure 6C, mTOR overexpression led to a dra-
matic increase in translation rates in growing cells. We
next examined how overexpression of the downstream
effectors of mTOR, eIF4E and S6K1, would affect cap-
dependent translation. We observed that both eIF4E
and S6K1 also enhanced cap-dependent translation
relative to the control. To test our model that S6K1 as-
sociation with the eIF3-PIC was important with regard
to its role in translation initiation, we measured the ef-
fect of overexpressing the nonphosphorylatable T389A-
S6K1 or F5A-S6K1 mutants, which bind constitutively
to the complex. Overexpression of both mutants led to
a decrease in translation, which was comparable to se-
rum starvation or rapamycin treatment of growing cells.
The use of both mutants also indicates that inhibition
of translation was not due to competition of the overex-
pressed TOS motif within the T389A mutant with
mTOR/raptor signaling to 4E-BP1, as the F5A mutant
contains a TOS-motif mutation but still significantly in-
terferes with translation. Overexpression of T389E mu-
tant, which does not to bind the complex, did not have
an effect on translation rates. Lastly, we tested the ef-
fect of eIF4B overexpression in this system. Overex-
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uression of wild-type eIF4B enhanced cap-dependent
ranslation. Additionally, overexpression of the mutant
IF4B S422D mimicking S6K1 phosphorylation had an
ven greater effect on cap-dependent translation. Over-
xpression of S422A-eIF4B mutant, which does not as-
ociate with the complex, had no effect on translation.
herefore, mTOR, S6K1, and eIF4B positively modulate
ap-dependent translation.
iscussion
ntil now, it was unclear how S6K1 participated in
ranslation initiation. We have identified the eIF3-PIC
s a dynamic scaffold for mTOR- and S6K1-mediated
ssembly of the translation initiation complex. The in-
eraction between S6K1 and the eIF3-PIC is governed
y the activating phosphorylation of S6K1 on the hy-
rophobic-motif residue T389. We have shown that
hosphorylation of T389 is critical for the release of
6K1 from the eIF3 complex. However, it is not known
hether T389 is a direct interface for interaction with
his complex or whether the phosphorylation of T389
eads to a conformational change that disrupts S6K1
nd eIF3-PIC binding. Importantly, other hydrophobic-
otif-containing AGC-family kinases do not appear to
nteract with the eIF3-PIC in unstimulated or stimulated
ells. Additionally, PDK1, which participates in hy-
rophobic-motif interactions, does not interact with
his scaffold. This is of importance as PDK1 association
ith S6K1 has been reported to be enhanced following
hosphorylation of the hydrophobic motif (Frodin et al.,
002). Once phosphorylated by mTOR/raptor at T389,
6K1 would be released, become accessible, and in-
eract with PDK1, which would then promote phos-
horylation of the S6K1 activation loop (T229) (see Fig-
re 7). This would promote full activation of S6K1, and
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577Figure 6. Insulin, Rapamycin, and Components of the mTOR Signaling Pathway Regulate Cap-Dependent Translation
(A) Structure of the bicistronic reporter plasmid allowing cap-dependent expression of renilla luciferase and expression of firefly luciferase
dependent on HCV IRES.
(B) Cap-dependent translation is insulin stimulated and rapamycin sensitive. HEK293E cells were transfected in triplicate with the reporter
plasmid and serum starved. Twenty-four hours posttransfection, cells were stimulated with insulin or pretreated with rapamycin and stim-
ulated with insulin for an additional 24 hr. Luciferase activities were measured by a dual-luciferase assay, and the renilla/firefly luciferase
light-unit ratio was calculated. The value of the serum-starved sample was set at 100%. Data are presented as the mean ± standard error.
(C) Overexpression of proteins in the mTOR pathway modulates cap-dependent translation. Cells were transfected with the bicistronic repor-
ter plasmid and the indicated proteins. Twenty-four hours posttransfection, cells were grown for an additional 24 hr in 10% serum (control),
serum-free media (serum-starved), or 10% serum in the presence of rapamycin. Cells transfected to express the indicated proteins were
grown in 10% serum. Luciferase activities were measured as in (B). The value of the control was set at 100%. Data are presented as the
mean ± standard error. Statistical significance was determined by Student’s t test. *p = 0.01, §p = 0.02, §§p < 0.001, **p < 0.005, #p < 0.008; each
data set was compared to the 100% control. The dashed line is drawn through the mean value of the control sample to facilitate comparison.T389 phosphorylation could be maintained in the ab-
sence of a direct input from mTOR by a PDK1/PKCζ-
regulated autophosphorylation mechanism as we have
proposed (Romanelli et al., 2002).
The series of results obtained in this study allow us
to postulate the following model for the regulated as-
sembly and activation of an efficient translation initi-
ation complex by mTOR/raptor and S6K1 (Figure 7).
Under basal conditions, S6K1 is bound to the eIF3
complex, whereas mTOR association is greatly re-
duced. The interaction of mTOR and S6K1 with the eIF3
complex is dynamic and sensitive to serum starvation,
insulin stimulation, and/or rapamycin treatment. The
molecular details of this interaction have yet to be de-
fined. The fact that rapamycin treatment reverses the
effect of insulin or growth-factor treatment is important
as it demonstrates that the observations made here are
not simply related to starvation and stimulation condi-
tions but are also relevant to conditions where themTOR pathway is inappropriately activated and trans-
lation rates upregulated. For example, in cancers with
activated PI3 kinase or loss of PTEN function, rapa-
mycin should be very effective at reversing the biologi-
cal consequences of inappropriately activated S6K1
signaling.
Thus, following an activating signal, such as insulin
stimulation, mTOR/raptor is recruited to the eIF3-PIC,
leading to phosphorylation of the bound and inactive
S6K1 on T389. Phosphorylated S6K1 is then released
from the eIF3 complex. Based on our sucrose-gradient
profiles, 7-methylguanosine cap-bead pull-downs, and
m7GTP elution experiments, the eIF3 to which S6K1
binds appears not to be associated with 40S subunits
and may be “free” and/or loosely associated with eIF4E
bound to the mRNA 5# cap. This observation has fur-
ther significance in that it also places the recruited
mTOR/raptor into position to phosphorylate 4E-BP1,
the eIF4E bound suppressor of cap-dependent transla-
Cell
578Figure 7. Model of Dynamic Interaction between the eIF3 Complex and mTOR/Raptor, S6K1, and eIF4B
Under basal conditions, S6K1 is associated with the eIF3 complex. Upon mitogen stimulation, an activation complex is formed in which
mTOR/raptor is recruited to the eIF3 complex and phosphorylatea S6K1 and 4E-BP1. Phosphorylation of S6K1 at T389 leads to its dissoci-
ation from the eIF3 complex (A). T389-phosphorylated S6K1 then binds to PDK1, which phosphorylates S6K1 at T229. The fully activated
S6K1 then phosphorylates eIF4B and S6 (B). Phosphorylation of eIF4B at S422 promotes its association with the translation preinitiation
complex. Concurrently, mTOR/raptor phosphorylates 4E-BP1 (A), which dissociates from the cap complex, allowing recruitment of the eIF4G
scaffold to the cap bound eIF4E as part of the eIF4F translation initiation complex (B). This sequence of events leads to preinitiation-complex
assembly and initiation of protein translation.tion. Thus the eIF3 complex acts as a scaffold allowing
mTOR/raptor to promote the coordinated regulation of
4E-BP1 and S6K1 phosphorylation. Since PDK1 is not
part of this scaffold complex, PDK1 must interact with
T389-phosphorylated S6K1 after its dissociation, allow-
ing for T229 phosphorylation within its activation loop
and catalytic activation (Figure 7B). Activated S6K1
then phosphorylates eIF4B and the 40S ribosomal sub-
unit protein S6. The S6K1 substrate eIF4B, when phos-
phorylated, is then recruited to the eIF3:40S ribosomal
subunit preinitiation complex. The recruitment of phos-
phorylated eIF4B is not dependent upon the recruit-
ment of eIF4G and the eIF4A helicase as the nonphos-
phorylatable 4E-BP1 (F114A) blocks insulin-stimulated
recruitment of eIF4G to the cap complex without affect-
ing recruitment of eIF4B. eIF4B recruitment is, however,
antagonized by nonphosphorylatable mutants of S6K1,
whereas eIF4G binding to the cap complex is not. Pre-
vious studies have shown that the helicase subunit
eIF4A has low activity in the absence of eIF4B (Lawson
et al., 1988; Rogers et al., 1999). Therefore, eIF4B phos-
phorylation by S6K1 provides a mechanism for recruit-
ment of eIF4B to eIF4A at the translation initiation com-
plex. The molecular details of how eIF4B and eIF4A
t
c
i
e
t
S
c
c
v
i
f
o
a
t
t
b
i
d
e
c
d
g
(hen function together remains to be defined, but their
orecruitment increases mRNA binding and processiv-
ty of the activated helicase complex, thus potentially
nhancing translation rates of mRNAs with long, struc-
ured 5# untranslated regions. Thus, eIF3, mTOR, and
6K1 coordinate the assembly of a translation initiation
omplex with enhanced translational capacity under
onditions of nutrient and energy sufficiency that acti-
ate mTOR, combined with additional S6K1-activating
nputs regulated by hormones such as insulin, growth
actors, tumor-promoting phorbol esters, or a variety of
ncogenic proteins (Fingar and Blenis, 2004; Martin
nd Blenis, 2002). Under these conditions, this transla-
ion initiation complex will be particularly efficient in the
ranslation of mRNAs encoding proteins involved in ri-
osome biogenesis due to S6 phosphorylation (Jeffer-
es et al., 1997), capped mRNAs due to mTOR-depen-
ent phosphorylation of 4E-BP1 and recruitment of
IF4G (Fingar and Blenis, 2004), and mRNAs with long,
omplex 5#UTRs due to the phosphorylation-depen-
ent recruitment of eIF4G (Fingar and Blenis, 2004; Gin-
ras et al., 2001) and the eIF4A/B helicase complex
Hay and Sonenberg, 2004).
The increase in ribosome production combined with
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579the enhanced translation efficiency of mRNAs encoding
proteins involved in G1 progression is necessary for cell
growth and cell-cycle progression (Fingar and Blenis,
2004; Richardson et al., 2004). Therefore, elucidation of
signaling interactions that feed into regulation of pro-
tein synthesis is important for understanding how cells
respond to growth and proliferation cues and, when im-
properly regulated, contribute to a variety of diseases.
Experimental Procedures
Plasmids and Stable Cell Lines
pRK7-HA-S6K1 was described previously (Cheatham et al., 1995;
Schalm et al., 2005). pcDNA3-AU-mTOR was provided by Robert
Abraham (Burnham Institute, San Diego, California) and has been
described (Brunn et al., 1997). pRK5-myc-raptor was provided by
David Sabatini (MIT, Cambridge, Massachusetts) and has been de-
scribed (Kim et al., 2002). The pCDNA3-FLAG-eIF4B constructs
were provided by John Hershey (University of California, Davis,
California) and have been described (Raught et al., 2004). Reporter
plasmid pRL-HCV-FL was provided by Martin Kruger (Medizinische
Hochschule Hannover, Hannover, Germany) and has been de-
scribed (Kruger et al., 2001). pACTAG-2/3HA-BP1 was provided by
Nahum Sonenberg (McGill University, Montreal), and generation of
the F114A mutant has been described (Schalm et al., 2003).
The TAP vector was generated by cloning nucleotides 262–1104
encoding the first 340 amino acids of the Staphylococcus aureus
Protein A followed by the TEV cleavage sequence into the BamHI,
EcoRI sites of the pBABE vector. Protein A-S6K1 fusion was gener-
ated by in-frame ligation of HA-S6K1 into the EcoRI, SalI sites of
the TAP vector. Stable cell lines were generated by transfecting the
TAP vector or TAP-S6K1 into HEK293E cells, followed by selection
in puromycin (Sigma).
Cell Culture, Transfection, Lysis, Coimmunoprecipitations,
and Immunoblotting
HEK293E cells were cultured, transfected, and lysed for immunoblot-
ting and coimmunoprecipitation as described previously (Martin et al.,
2001). For experiments involving mTOR/raptor, HEK293E cells were
cultured, transfected, and lysed for immunoblotting and coimmu-
noprecipitation as described previously (Schalm et al., 2003). After
20 hr of starvation in serum-free DMEM, cells were pretreated for
30 min with rapamycin (20 ng/ml) or ethanol vehicle and then stim-
ulated with insulin (100 mM), EGF (50 ng/ml), or PMA (100 ng/ml)
for 30 min. For amino acid starvation and restimulation experi-
ments, after 20 hr of starvation in serum-free DMEM, U2OS or HeLa
cells were starved for 1 hr in Dulbecco’s PBS, pretreated for 30 min
with rapamycin (20 ng/ml) or ethanol vehicle, and stimulated for
1 hr with MEM amino acid solution (GIBCO). Cell extracts were
immunoprecipitated with the indicated antibodies for 2 hr, followed
by incubation with 1:1 mixture of Protein A-Sepharose CL4B beads
(Pharmacia) and Protein G beads (Sigma) for 1 hr. For cap binding
assays, lysates were incubated with 7-methyl-GTP Sepharose (Am-
ersham) for 2 hr. Immunoprecipitates were washed with lysis buffer.
Proteins were resolved by SDS-PAGE, transferred onto nitrocellu-
lose (Schleicher and Schuell), and probed with the indicated anti-
bodies.
Antibodies
Anti-myc monoclonal antibodies were purchased from Charles
River Laboratories. Anti-HA monoclonal antibodies were kindly pro-
vided by Margaret Chou (University of Pennsylvania, Philadelphia).
Anti-AU1 mononoclonal antibodies were from Covance. Anti-phos-
pho-S6 antibodies were kindly provided by Morris Birnbaum (Uni-
versity of Pennsylvania and HHMI, Philadelphia). Anti-eIF3, anti
eIF4G, anti-mTOR, and 4E-BP1 antibodies were purchased from
Santa Cruz Biotechnology. Anti-p70S6K antibody was described
previously (Romanelli et al., 1999). Anti-Akt, anti-S6K1 T389, anti-
S6, anti-eIF4E, anti-raptor, anti-4E-BP1 P-S65, anti-eIF4B, and
P-S422 antibodies were purchased from Cell Signaling Technology.
Anti-PDK1 antibodies were from Upstate USA, Inc. For immu-
noblotting, anti-rabbit, anti-mouse, and anti-goat horseradish per-oxidase (HRP) conjugated antibodies were purchased from Amer-
sham, Chemicon, and Santa Cruz Biotechnology, respectively.
Immune Complex Kinase Assay
S6K1 kinase assays were done as previously described (Romanelli
et al., 1999).
Tandem-Affinity Purification
Ten 15 cm plates of stably transfected, growing cells were lysed,
and lysates were incubated with IgG bead columns (Sigma) for 2
hr at 4°C. IgG columns were washed twice with 10 ml lysis buffer
and equilibrated with 50 mM Tris (pH 8.0). TEV cleavage reaction
was performed as described by the manufacturer (Invitrogen Life
Technologies) for 2 hr at 4°C. The eluant was incubated with HA-
antibody coupled to Affigel matrix (Bio-Rad) for 1 hr at 4°C. The
matrix was washed with 10 ml lysis buffer. The associated proteins
were eluted with 1 M MgCl2, 50 mM HEPES (pH 7.2) followed by
TCA precipitation. Precipitates were washed with acetone and re-
solved using 4%–12% SDS-PAGE.
Bicistronic Luciferase Assay
For luciferase reporter experiments, HEK293E cells were trans-
fected with pRL-HCV-FL reporter plasmid (Kruger et al., 2001) and
the indicated DNA. Forty-eight hours posttransfection, cells were
harvested, and the luciferase activity was measured using Dual-
Luciferase Reporter Assay System (Promega) and Turner Designs
TD-20/20 luminometer according to the manufacturers’ instruc-
tions.
Mass Spectrometry
Gel bands were excised, diced, and subjected to in-gel digestion
with sequencing grade trypsin (Promega, 12.5 ng/l) in 50 mM am-
monium bicarbonate overnight at 37°C. Peptides were extracted
with 50% acetonitrile (ACN), 5% formic acid (FA) and then dried.
Peptides were then resuspended in 2.5% ACN, 5% FA and loaded
using an autosampler onto a microcapillary column (100 m × 12
cm) packed with reverse-phase MagicC18 material (5 m, 200 Å,
Michrom Bioresources, Inc.). Elution was achieved with a 5%–35%
ACN (0.1% FA) gradient over 60 min, after a 20 min isocratic load-
ing at 2.5% ACN, 0.5% FA. Mass spectra were acquired on a LCQ-
Deca XP (Thermo Electron) over the entire run using eight MS/MS
scans following each survey scan. Raw data were searched for fully
tryptic peptides against the NCBI nonredundant human database
using Sequest software and a mass allowance of 2 Da.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and three figures and can be found with this article online at http://
www.cell.com/cgi/content/full/123/4/569/DC1/.
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